A multi-drug resistant pathogen reference strain and clinical isolate collection

MEDICINES DISCOVERY CATAPULT SERVICES LIMITEDcontractContracts FinderRef Medicines Discovery Catapultcomplete
View buyer

Estimated value

£696k

Awarded value

£696k

Awarded 13 Dec 2023

Suppliers

1

Lots

1

1 awarded

Published

07 Feb 2024

Deadline 13 Dec 2023

Description

A multi-drug resistant pathogen reference strain and clinical isolate collection representative of pathogens and resistance mechanisms directly aligned to the PACE first funding call that can be used by the provider to generate antimicrobial susceptibility data across PACE-funded projects and that can be made available to PACE awardees for onward project progression. Continued expansion and characterisation of the strain and isolate collection to ensure it remains reflective of contemporary and genomically diverse multi-drug resistant and epidemic lineages of target pathogens (~20-30 strains) across E. coli, K. pneumoniae, P. aeruginosa, A. baumannii and S. aureus. This expanded collection will be made available for antimicrobial susceptibility testing (AST) across PACE-funded projects and the wider AMR community.

Scope

Reference
Medicines Discovery Catapult
Total value
£695,718 excluding VAT
Commercial tool
Standalone contract
Contract dates
04 Jan 2024 to 31 Aug 2028
CPV classifications
73200000

Submission & procedure

Submission deadline
13 Dec 2023, 12:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£696k

Award date

13 Dec 2023

Contract start

04 Jan 2024

Contract end

31 Aug 2028